These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 22428773)

  • 21. Efficacy and safety of lesogaberan in gastro-oesophageal reflux disease: a randomised controlled trial.
    Shaheen NJ; Denison H; Björck K; Karlsson M; Silberg DG
    Gut; 2013 Sep; 62(9):1248-55. PubMed ID: 22730470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial.
    Dickman R; Emmons S; Cui H; Sewell J; Hernández D; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2005 Sep; 22(6):547-55. PubMed ID: 16167971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of a novel metabotropic glutamate receptor 5 antagonist (AZD2066) on transient lower oesophageal sphincter relaxations and reflux episodes in healthy volunteers.
    Rohof WO; Lei A; Hirsch DP; Ny L; Astrand M; Hansen MB; Boeckxstaens GE
    Aliment Pharmacol Ther; 2012 May; 35(10):1231-42. PubMed ID: 22469098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postprandial High-Resolution Impedance Manometry Identifies Mechanisms of Nonresponse to Proton Pump Inhibitors.
    Yadlapati R; Tye M; Roman S; Kahrilas PJ; Ritter K; Pandolfino JE
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):211-218.e1. PubMed ID: 28911949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients.
    Sweis R; Kaufman E; Anggiansah A; Wong T; Dettmar P; Fried M; Schwizer W; Avvari RK; Pal A; Fox M
    Aliment Pharmacol Ther; 2013 Jun; 37(11):1093-102. PubMed ID: 23600790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of a 5-HT(4) receptor agonist on oesophageal function and gastro-oesophageal reflux: studies using combined impedance-manometry and combined impedance-pH.
    Tutuian R; Mainie I; Allan R; Hargreaves K; Agrawal A; Freeman J; Gale J; Castell DO
    Aliment Pharmacol Ther; 2006 Jul; 24(1):155-62. PubMed ID: 16803614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The gastric accommodation response to meal intake determines the occurrence of transient lower esophageal sphincter relaxations and reflux events in patients with gastro-esophageal reflux disease.
    Pauwels A; Altan E; Tack J
    Neurogastroenterol Motil; 2014 Apr; 26(4):581-8. PubMed ID: 24533836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cigarette smoking on gastroesophageal reflux measured by 24-h ambulatory esophageal pH monitoring.
    Kadakia SC; Kikendall JW; Maydonovitch C; Johnson LF
    Am J Gastroenterol; 1995 Oct; 90(10):1785-90. PubMed ID: 7572895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baclofen for the treatment of pediatric GERD.
    Vadlamudi NB; Hitch MC; Dimmitt RA; Thame KA
    J Pediatr Gastroenterol Nutr; 2013 Dec; 57(6):808-12. PubMed ID: 23838820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trial: a controlled trial of baclofen add-on therapy in PPI-refractory gastro-oesophageal reflux symptoms.
    Pauwels A; Raymenants K; Geeraerts A; Boecxstaens V; Masuy I; Broers C; Vanuytsel T; Tack J
    Aliment Pharmacol Ther; 2022 Jul; 56(2):231-239. PubMed ID: 35665521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of anti-reflux surgery on weakly acidic reflux and belching.
    Broeders JA; Bredenoord AJ; Hazebroek EJ; Broeders IA; Gooszen HG; Smout AJ
    Gut; 2011 Apr; 60(4):435-41. PubMed ID: 21193452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baclofen-mediated gastro-oesophageal acid reflux control in patients with established reflux disease.
    Cange L; Johnsson E; Rydholm H; Lehmann A; Finizia C; Lundell L; Ruth M
    Aliment Pharmacol Ther; 2002 May; 16(5):869-73. PubMed ID: 11966493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 24-hour ambulatory pH-metry in patients with refractory heartburn: a prospective study.
    Talaie R; Forootan M; Donboli K; Dadashzadeh N; Sadeghi A; Poorsaadat S; Moghimi B; Mohammad Alizadeh AH; Zali MR
    J Gastrointestin Liver Dis; 2009 Mar; 18(1):11-5. PubMed ID: 19337627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastroesophageal reflux symptoms in typical and atypical GERD: roles of gastroesophageal acid refluxes and esophageal motility.
    Patcharatrakul T; Gonlachanvit S
    J Gastroenterol Hepatol; 2014 Feb; 29(2):284-90. PubMed ID: 23926926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux.
    Wo JM; Koopman J; Harrell SP; Parker K; Winstead W; Lentsch E
    Am J Gastroenterol; 2006 Sep; 101(9):1972-8; quiz 2169. PubMed ID: 16968502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cisapride in the treatment of gastro-oesophageal reflux disease.
    Robertson CS; Evans DF; Ledingham SJ; Atkinson M
    Aliment Pharmacol Ther; 1993 Apr; 7(2):181-90. PubMed ID: 8485271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of lesogaberan, a novel GABA(B)-receptor agonist, on transient lower oesophageal sphincter relaxations in male subjects.
    Boeckxstaens GE; Rydholm H; Lei A; Adler J; Ruth M
    Aliment Pharmacol Ther; 2010 Jun; 31(11):1208-17. PubMed ID: 20222915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distension during gastroesophageal reflux: effects of acid inhibition and correlation with symptoms.
    Tipnis NA; Rhee PL; Mittal RK
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G469-74. PubMed ID: 17556589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel partial 5HT3 agonist DDP733 after a standard refluxogenic meal reduces reflux events: a randomized, double-blind, placebo-controlled pharmacodynamic study.
    Choung RS; Ferguson DD; Murray JA; Kammer PP; Dierkhising RA; Zinsmeister AR; Nurbhai S; Landau SB; Talley NJ
    Aliment Pharmacol Ther; 2008 Mar; 27(5):404-11. PubMed ID: 18081732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of baclofen on emesis and 24-hour esophageal pH in neurologically impaired children with gastroesophageal reflux disease.
    Kawai M; Kawahara H; Hirayama S; Yoshimura N; Ida S
    J Pediatr Gastroenterol Nutr; 2004 Mar; 38(3):317-23. PubMed ID: 15076634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.